Abstract
The complex inertness of 99mTc-EHDP, -MDP, -PPi and -TriP was determined in vitro by means of protein binding of 99mTc after dilution in a phosphate-buffered albumin solution. Commercially available kits were used. In vitro, 99mTc-EHDP was found to be the most stable complex. The biodistribution of these agents was evaluated in the adult rat; here the less stable 99mTc-MDP proved to be the superior bone imaging agent. It is suggested that the complex inertness and the bone affinity are opposing properties of the 99mTc-phosphate compounds, because the complex must hydrolyse before the phosphate compound and technetium (IV) are deposited separately in bone. Hence, bone imaging with 99mTc-phosphate compounds demands a compromise concerning the stability of these complexes at low ligand concentrations, which among the investigated agents is best accomplished by 99mTc-MDP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
